Evidence map›Paper›PMID 31848205›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2020

Biomarkers of Exposure and Effect in the Lungs of Smokers, Nonsmokers, and Electronic Cigarette Users.

Min-Ae Song, Jo L Freudenheim, Theodore M Brasky, Ewy A Mathe, Joseph P McElroy, Quentin A Nickerson, Sarah A Reisinger, Dominic J Smiraglia, Daniel Y Weng, Kevin L Ying and 2 more

Open access · greenAbstract readComparative Study
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 4 pooled it
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 4 syntheses or guidelines pooled it, 69 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Review
  7. Article
  8. Article
  9. Article
  10. E-CIGARETTE FLAVOR RESTRICTIONS' EFFECTS ON TOBACCO PRODUCT SALES.American journal of health economics · 2026
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Biomarkers of Exposure to Nicotine and Selected Toxicants in Individuals Who Use Alternative Tobacco Products Sold in Japan and Canada from 2018 to 2019.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Article
  17. Article
  18. Review
  19. Sex-specific lung inflammation and mitochondrial damage in a model of electronic cigarette exposure in asthma.American journal of physiology. Lung cellular and molecular physiology · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Min-Ae SongComprehensive Cancer Center, The Ohio State University and James Cancer Hospital, Columbus, Ohio.
Jo L FreudenheimDepartment of Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo, Buffalo, New York.ORCID 0000-0002-9301-0499
Theodore M BraskyComprehensive Cancer Center, The Ohio State University and James Cancer Hospital, Columbus, Ohio.
Ewy A MatheComprehensive Cancer Center, The Ohio State University and James Cancer Hospital, Columbus, Ohio.
Joseph P McElroyComprehensive Cancer Center, The Ohio State University and James Cancer Hospital, Columbus, Ohio.ORCID 0000-0003-0366-1210
Quentin A NickersonComprehensive Cancer Center, The Ohio State University and James Cancer Hospital, Columbus, Ohio.
Sarah A ReisingerComprehensive Cancer Center, The Ohio State University and James Cancer Hospital, Columbus, Ohio.ORCID 0000-0002-3076-5405
Dominic J SmiragliaDepartment of Cancer Genetics and Genomics, Roswell Park Cancer Institute, Buffalo, New York.ORCID 0000-0001-8852-1510
Daniel Y WengComprehensive Cancer Center, The Ohio State University and James Cancer Hospital, Columbus, Ohio.
Kevin L YingComprehensive Cancer Center, The Ohio State University and James Cancer Hospital, Columbus, Ohio.
Mark D WewersPulmonary and Critical Care Medicine, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.ORCID 0000-0002-7079-5633
Peter G ShieldsComprehensive Cancer Center, The Ohio State University and James Cancer Hospital, Columbus, Ohio. Peter.Shields@osumc.edu.
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute · USRoswell Park Comprehensive Cancer Center · USThe Ohio State University · USUniversity at Buffalo, State University of New York · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI WANCAI YANG · 1985 to 2026
$132.3M
The Ohio State University Center for clinical and Translational ScienceUL1TR001070 · NCATS · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2013 to 2017
$22.6M
Project 4: Comprehension of Health Risks in More and Less Arousing Affe p240-275P50CA180908 · NCI · OHIO STATE UNIVERSITY · PI SHIELDS, PETER G., WEWERS, MARY ELLEN · 2013 to 2017
$18.9M
Mitochondrial Genetic Alterations: A clinical trial of a standardized research e-cigaretteR21HL147401 · NHLBI · OHIO STATE UNIVERSITY · PI SONG, MIN-AE · 2019 to 2020
$429k
NCATS NIH HHS UL1 TR001070NCI NIH HHS P30 CA016058NCI NIH HHS P50 CA180908NHLBI NIH HHS R21 HL147401
6 · The paper itself

Abstract

backgroundNicotine-containing electronic cigarette (e-cig) use has become widespread. However, understanding the biological impact of e-cigs compared with smoking on the lung is needed. There are major gaps in knowledge for chronic effects and for an etiology to recent acute lung toxicity leading to death among vapers.

methodsWe conducted bronchoscopies in a cross-sectional study of 73 subjects (42 never-smokers, 15 e-cig users, and 16 smokers). Using bronchoalveolar lavage and brushings, we examined lung inflammation by cell counts, cytokines, genome-wide gene expression, and DNA methylation.

resultsThere were statistically significant differences among never-smokers, e-cig users, and smokers for inflammatory cell counts and cytokines (FDR

conclusionsThese data indicate that e-cigs are associated with less toxicity than cigarettes for smoking-related pathways. What is unknown may be unique effects for e-cigs not measured herein, and a comparison of smokers completely switching to e-cigs compared with former smokers. Clinical trials for smokers switching to e-cigs who undergo serial bronchoscopy and larger cross-sectional studies of former smokers with and without e-cig use, and for e-cigs who relapse back to smoking, are needed. IMPACT: These data can be used for product regulation and for informing tobacco users considering or using e-cigs. What is unknown may be unique effects for e-cigs not measured herein, and clinical trials with serial bronchoscopy underway can demonstrate a direct relationship for changes in lung biomarkers.

Indexed as

Electronic Nicotine Delivery SystemsAdultBiomarkersBronchoalveolar Lavage FluidBronchoscopyCell CountCigarette SmokingCytokinesDNA MethylationFemaleGene Expression ProfilingHumansLungMaleNon-SmokersSmokersBiomarkersCytokines

Identifiers

PMID31848205
PMCPMC7064803
OpenAlexW2995992449

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.